Cumberland Pharmaceuticals (CPIX) Short-term Investments (2012 - 2018)
Cumberland Pharmaceuticals (CPIX) posted Short-term Investments of $8.3 million for Q4 2018, up 77.44% sequentially from $4.7 million in Q4 2017, and up 77.44% YoY from $4.7 million in Q4 2017.
Cumberland Pharmaceuticals (CPIX) Short-term Investments (2012 - 2018) Analysis & Trends
Cumberland Pharmaceuticals has reported Short-term Investments for 7 years, with the latest figure at $8.3 million in Q4 2018.
- Quarterly Short-term Investments rose 77.44% year-over-year to $8.3 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $8.3 million (up 77.44% YoY) and the FY2018 annual result came in at $8.3 million, up 77.44% from the prior year.
- Short-term Investments climbed to $8.3 million in Q4 2018 per CPIX's latest filing, from $4.7 million in the prior quarter.
- Over five years, Short-term Investments peaked at $15.6 million in Q4 2016 and troughed at $4.7 million in Q4 2017.
- A 5-year average of $11.6 million and a median of $14.6 million in 2015 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2017 and 2018: Short-term Investments sank 70.09% in 2017, then soared 77.44% in 2018.
- Over 5 years, Short-term Investments stood at $14.8 million in 2014, then decreased by 1.87% to $14.6 million in 2015, then rose by 7.26% to $15.6 million in 2016, then tumbled by 70.09% to $4.7 million in 2017, then soared by 77.44% to $8.3 million in 2018.
- According to Business Quant data, Short-term Investments over the past three periods registered $8.3 million, $4.7 million, and $15.6 million for Q4 2018, Q4 2017, and Q4 2016 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 8.29 Mn |
| Dec 31, 2017 | 4.67 Mn |
| Dec 31, 2016 | 15.62 Mn |
| Dec 31, 2015 | 14.56 Mn |
| Dec 31, 2014 | 14.84 Mn |
| Dec 31, 2013 | 14.02 Mn |
| Dec 31, 2012 | 16.69 Mn |